Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01473095
Title Phase 1 Dose Escalation Study of ARQ 092 in Adult Subjects With Advanced Solid Tumors and Recurrent Malignant Lymphoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors ArQule
Indications

lymphoma

Advanced Solid Tumor

Therapies

Miransertib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.